Evidence map›Paper›PMID 23918578›Full record

Trial reportYonsei medical journal2013

Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis.

Seiji Ohtori, Gen Inoue, Sumihisa Orita, Masashi Takaso, Yawara Eguchi, Nobuyasu Ochiai, Shunji Kishida, Kazuki Kuniyoshi, Yasuchika Aoki, Tetsuhiro Ishikawa and 12 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Yonsei medical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Psychotropic Drug Use in Korean Patients With Osteoarthritis.Journal of Korean medical science · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Non-surgical treatments for the management of early osteoarthritis.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Seiji OhtoriDepartment of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. sohtori@faculty.chiba-u.jp
Gen Inoue
Sumihisa Orita
Masashi Takaso
Yawara Eguchi
Nobuyasu Ochiai
Shunji Kishida
Kazuki Kuniyoshi
Yasuchika Aoki
Tetsuhiro Ishikawa
Masayuki Miyagi
Hiroto Kamoda
Miyako Suzkuki
Junichi Nakamura
Gou Kubota
Yoshihiro Sakuma
Yasuhiro Oikawa
Tomoaki Toyone
Kazuhide Inage
Takeshi Sainoh
Kazuyo Yamauchi
Kazuhisa Takahashi
Chiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOsteoarthritic pain is largely considered to be inflammatory pain. Sensory nerve fibers innervating the knee have been shown to be significantly damaged in rat models of knee osteoarthritis (OA) in which the subchondral bone junction is destroyed, and this induces neuropathic pain (NP). Pregabalin was developed as a pain killer for NP; however, there are no reports on pregabalin use in OA patients. The purpose of this study was to investigate the efficacy of pregabalin for pain in OA patients. MATERIALS AND

methodsEighty-nine knee OA patients were evaluated in this randomized prospective study. Patients were divided into meloxicam, pregabalin, and meloxicam+pregabalin groups. Pain scores were evaluated before and 4 weeks after drug application using a visual analogue scale (VAS), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Pain scales among groups were compared using a Kruskal-Wallis test.

resultsBefore drug application, there was no significant difference in VAS and WOMAC scores among the three groups (p>0.05). Significant pain relief was seen in the meloxicam+pregabalin group in VAS at 1, 2, and 4 weeks, and WOMAC score at 4 weeks, compared with the other groups (p<0.05). No significant pain relief was seen in the meloxicam only group in VAS during 4 weeks and WOMAC score at 4 weeks compared with the pregabalin only group (p>0.05).

conclusionMeloxicam+pregabalin was effective for pain in OA patients. This finding suggests that OA pain is a combination of inflammatory and NP.

Indexed as

AgedAged, 80 and overDrug Therapy, CombinationFemalegamma-Aminobutyric AcidHumansMaleMeloxicamMiddle AgedOsteoarthritis, KneePain MeasurementPregabalinThiazinesThiazolesgamma-Aminobutyric AcidMeloxicamPregabalinThiazinesThiazolesinflammatorykneenerveneuropathicosteoarthritisPainpregabalin

Identifiers

PMID23918578
PMCPMC3743181
OpenAlexW2131442183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.